Position
Chief Financial Officer
Company
CytoSorbents Corporation
Monmouth JunctionManufacturingBiotechnologyHealth CareDescription
CytoSorbents Corporation announces the retirement of Kathleen P. Bloch, the current Chief Financial Officer, and the appointment of Peter J. Mariani as the new Chief Financial Officer, effective August 14, 2024.
Quick answer
CytoSorbents Appoints Peter J. Mariani as Chief Financial Officer (August 13, 2024). CytoSorbents Corporation is based in Monmouth Junction, New Jersey, United States.
- Who is the new Chief Financial Officer at CytoSorbents Corporation?
- CytoSorbents Corporation named Peter J. Mariani Chief Financial Officer, announced August 13, 2024.
- What did CytoSorbents Corporation announce on August 13, 2024?
- CytoSorbents Corporation announces the retirement of Kathleen P. Bloch, the current Chief Financial Officer, and the appointment of Peter J. Mariani as the new Chief Financial Officer, effective August 14, 2024.
- What does CytoSorbents Corporation do?
- CytoSorbents Corporation (NASDAQ: CTSO) is a New Jersey-based company involved in the R&D and commercialization of medical devices using its proprietary polymer adsorption technology.
- Where is CytoSorbents Corporation based?
- CytoSorbents Corporation is based in Monmouth Junction, New Jersey, United States.
- Which similar companies made leadership changes around the same time?
- ENDRA Life Sciences (August 13, 2024), North Coast Medical (August 14, 2024), Trinity Biotech (August 20, 2024) and Tenon Medical (August 27, 2024) also announced leadership changes within 45 days of CytoSorbents Corporation.
Source: Fundz verified event record.
Other recent leadership changes in Manufacturing and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- ENDRA Life Sciences Inc. Appoints Alexander Tokman as Acting Chief Executive Officer and Adds Ziad Rouag as Head of Regulatory and Clinical Affairs and Richard Jacroux as Chief Financial Officer (August 13, 2024)
- Adam C. Buglio Joins North Coast Medical, Inc. as Chief Revenue Officer (CRO) (August 14, 2024)
- Trinity Biotech Appoints David Ouston as Biosensor Marketing Director (August 20, 2024)
- Tenon Medical Appoints Kevin Williamson as Chief Financial Officer (August 27, 2024)
- Quantum-Si Appoints Todd Bennett as Chief Commercial Officer and John Vieceli, Ph.D. as Chief Product Officer (August 27, 2024)
- Amsel Medical Corporation Appoints James A. Heinz, MSL as Chief Executive Officer (July 30, 2024)
Who to call at CytoSorbents Corporation, and when
A new leader at CytoSorbents Corporation brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day CytoSorbents Corporation raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CytoSorbents Corporation, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CytoSorbents Corporation. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CytoSorbents Corporation changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
CytoSorbents Corporation changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.